A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

Clinical trial NCT03926130 · COMPLETED

Trial details

NCT number: NCT03926130
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2019-07-23
Primary completion: 2023-08-23
Enrollment: 1158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.